TEM announces the acquisition of Deep 6 AI, enhancing its AI-driven clinical trial matching capabilities to accelerate patient recruitment and revolutionize precision medicine.

Cathie Wood’s ARK line of ETFs added more 29,845 Tempus AI (TEM) stock after the company announced the acquisition of Deep 6 AI ...

EDT Cathie Wood’s ARK Investment bought 30K shares of Tempus AI (TEM) todayLight Up your Portfolio with Spark:Easily identify stocks' ...

Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings in the... In a recent transaction, West Nadja, a director at Tempus AI , Inc ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

The excitement around reasoning models like OpenAI’s o1 and DeepSeek’s R1 got me thinking: How much are businesses actually using them?The answer might be: not as much as you’d think.When I ask ...

D-Wave Quantum Inc. (NYSE:QBTS) shares are trading higher on Thursday. Today, the company reported fourth-quarter adjusted ...

U.S. President Donald Trump has threatened to impose a 200% tariff on alcoholic products from the European Union, in response ...

Javelin Minerals Limited ( ($AU:JAV) ) has issued an update. Javelin Minerals Limited has released its half-year financial report for the period ...

Adobe's dull forecast raises AI monetization doubts, shares fall Adobe forecast second-quarter revenue in line with Wall Street expectations on Wednesday, as it grapples with slower monetization ...